8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors

被引:15
作者
Thomas, Allen A. [1 ]
Hunt, Kevin W. [1 ]
Newhouse, Brad [1 ]
Watts, Ryan J. [2 ]
Liu, Xingrong [2 ]
Vigers, Guy [1 ]
Smith, Darin [1 ]
Rhodes, Susan P. [1 ]
Brown, Karin D. [1 ]
Otten, Jennifer N. [1 ]
Burkard, Michael [1 ]
Cox, April A. [1 ]
Do, Mary K. Geck [1 ]
Dutcher, Darrin [1 ]
Rana, Sumeet [1 ]
DeLisle, Robert K. [1 ]
Regal, Kelly [1 ]
Wright, Albion D. [1 ]
Groneberg, Robert [1 ]
Liao, Jiangpeng [3 ]
Scearce-Levie, Kimberly [2 ]
Siu, Michael [2 ]
Purkey, Hans E. [2 ]
Lyssikatos, Joseph P. [2 ]
机构
[1] Array BioPharma, Boulder, CO 80301 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] WuXi AppTec Co Ltd, Shanghai 200131, Peoples R China
关键词
ALZHEIMERS-DISEASE; IN-VIVO; SECRETASE INHIBITORS; ASPARTIC PROTEASE; IODINE ISOCYANATE; SS-SECRETASE; CATHEPSIN-D; DESIGN; BRAIN; AMINOIMIDAZOLES;
D O I
10.1021/jm5015132
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2,3,4,4a,10,10a-hexahydropyrano[3,2-b]chromene analogs was developed that demonstrated high selectivity (>2000-fold) for BACE1 vs Cathepsin D (CatD). Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Guided by structure based design, changes to P2' and P3 moieties were explored. A conformationally restricted P2' methyl group provided inhibitors with excellent cell potency (37137 nM) and selectivity (435 to >2000-fold) for BACE1 vs CatD. These efforts lead to compound 59, which demonstrated a 69% reduction in rat CSF A beta(1-40) at 60 mg/kg (PO).
引用
收藏
页码:10112 / 10129
页数:18
相关论文
共 54 条
[1]  
Alzforum, 2014, CLOIST RETR TAK PULS
[2]  
Alzheimer's Association, 2014, FDAAPPROVED TREATMEN
[3]  
Alzheimer's Disease International, 2014, POL BRIEFS HEADS GOV
[4]  
Alzheimer's Disease International, 2014, WORLD ALZH REP 2010
[5]   CRYSTAL-STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN-D - IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN [J].
BALDWIN, ET ;
BHAT, TN ;
GULNIK, S ;
HOSUR, MV ;
SOWDER, RC ;
CACHAU, RE ;
COLLINS, J ;
SILVA, AM ;
ERICKSON, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6796-6800
[6]   Cathepsin D-Many functions of one aspartic protease [J].
Benes, Petr ;
Vetvicka, Vaclav ;
Fusek, Martin .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (01) :12-28
[7]   ß-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment [J].
Cai, Jun ;
Qi, Xiaoping ;
Kociok, Norbert ;
Skosyrski, Sergej ;
Emilio, Alonso ;
Ruan, Qing ;
Han, Song ;
Liu, Li ;
Chen, Zhijuan ;
Rickman, Catherine Bowes ;
Golde, Todd ;
Grant, Maria B. ;
Saftig, Paul ;
Serneels, Lutgarde ;
de Strooper, Bart ;
Joussen, Antonia M. ;
Boulton, Michael E. .
EMBO MOLECULAR MEDICINE, 2012, 4 (09) :980-991
[8]   From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) [J].
Cheng, Yuan ;
Judd, Ted C. ;
Bartberger, Michael D. ;
Brown, James ;
Chen, Kui ;
Fremeau, Robert T., Jr. ;
Hickman, Dean ;
Hitchcock, Stephen A. ;
Jordan, Brad ;
Li, Vivian ;
Lopez, Patricia ;
Louie, Steven W. ;
Luo, Yi ;
Michelsen, Klaus ;
Nixey, Thomas ;
Powers, Timothy S. ;
Rattan, Claire ;
Sickmier, E. Allen ;
St Jean, David J. ;
Wahl, Robert C. ;
Wen, Paul H. ;
Wood, Stephen .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (16) :5836-5857
[9]   Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles [J].
Cheret, Cyril ;
Willem, Michael ;
Fricker, Florence R. ;
Wende, Hagen ;
Wulf-Goldenberg, Annika ;
Tahirovic, Sabina ;
Nave, Klaus-Armin ;
Saftig, Paul ;
Haass, Christian ;
Garratt, Alistair N. ;
Bennett, David L. ;
Birchmeier, Carmen .
EMBO JOURNAL, 2013, 32 (14) :2015-2028
[10]   Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration [J].
Clark, DE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (08) :815-821